Tag Archives: Mark Massaro

Illumina (ILMN) Gets a Buy Rating from Canaccord Genuity

In a report released today, Mark Massaro from Canaccord Genuity maintained a Buy rating on Illumina (ILMN – Research Report), with a price target of $360. The company’s shares closed on Friday at $335.49. Massaro said: “We recently had the

HTG Molecular Diagnostics (HTGM) Receives a Rating Update from a Top Analyst

Canaccord Genuity analyst Mark Massaro maintained a Buy rating on HTG Molecular Diagnostics (HTGM – Research Report) yesterday and set a price target of $5. The company’s shares closed yesterday at $2.32, close to its 52-week low of $2.03. Massaro

Canaccord Genuity Remains a Buy on Quanterix Corporation (QTRX)

Canaccord Genuity analyst Mark Massaro maintained a Buy rating on Quanterix Corporation (QTRX – Research Report) today and set a price target of $32. The company’s shares closed yesterday at $23.24. Massaro commented: “We recommend investors own QTRX as it

Why Did Canaccord Genuity Downgrade Orasure Technologies’ Stock?

Orasure Technologies (OSUR – Research Report) received a Hold rating and a $10 price target from Canaccord Genuity analyst Mark Massaro today. The company’s shares closed yesterday at $9.75, close to its 52-week low of $8.75. Massaro noted: “We no

Canaccord Genuity Maintains Their Buy Rating on Chembio Diagnostics (CEMI)

Canaccord Genuity analyst Mark Massaro maintained a Buy rating on Chembio Diagnostics (CEMI – Research Report) today and set a price target of $10. The company’s shares opened today at $6.91. Massaro wrote: “We believe CEMI is an underappreciated small-cap

Canaccord Genuity Maintains Their Buy Rating on GenMark (GNMK)

Canaccord Genuity analyst Mark Massaro maintained a Buy rating on GenMark (GNMK – Research Report) yesterday and set a price target of $10. The company’s shares closed yesterday at $7.24. Massaro commented: “We are positive on the hire of the